Flat-rate pricing · Discounts available No commitment required · Cancel anytime Prescription included · 100% online · No lab work required Multiple pharmacy options · Third-party tested Free overnight shipping · Supplies included · Discreet packaging Money-back guarantee Tirzepatide, Semaglutide · Zepbound Auto-renewing plans Video consultation required · Other fees may apply Mixed additive-free options Not available in all statesProvider Plans Monthly Plan Tirzepatide Monthly
Dose Your Supply Your Price Your Supply Avg/mo Your Value 2.5mg/wk 10mg/mo $289.00 10mg $289 $28.90/mg 5.0mg/wk 20mg/mo $289.00 20mg $289 $14.45/mg 7.5mg/wk 30mg/mo $289.00 30mg $289 $9.63/mg 10.0mg/wk 40mg/mo $289.00 40mg $289 $7.22/mg 12.5mg/wk 50mg/mo $289.00 50mg $289 $5.78/mg 15.0mg/wk 60mg/mo $289.00 60mg $289 $4.82/mg
Zepbound Pen Tirzepatide Monthly Brand
Dose Your Supply Your Price Your Supply Avg/mo Your Value 2.5mg/wk 10mg/mo N/A 10mg N/A N/A 5.0mg/wk 20mg/mo N/A 20mg N/A N/A 7.5mg/wk 30mg/mo N/A 30mg N/A N/A 10.0mg/wk 40mg/mo N/A 40mg N/A N/A 12.5mg/wk 50mg/mo N/A 50mg N/A N/A 15.0mg/wk 60mg/mo N/A 60mg N/A N/A Consultation fee not included
Zepbound Vial Tirzepatide Monthly Brand
Dose Your Supply Your Price Your Supply Avg/mo Your Value 2.5mg/wk 10mg/mo N/A 10mg N/A N/A 5.0mg/wk 20mg/mo N/A 20mg N/A N/A 7.5mg/wk 30mg/mo N/A 30mg N/A N/A 10.0mg/wk 40mg/mo N/A 40mg N/A N/A 12.5mg/wk 50mg/mo N/A 50mg N/A N/A 15.0mg/wk 60mg/mo N/A 60mg N/A N/A Consultation fee not included
Provider Details Prescription Included Yes
Telehealth Included Yes
Online-Only Option Yes
Skip Labs Yes
Credit Money-Back Guarantee Sale: $50 off
Insurance Accepted No
HSA/FSA Accepted Yes
Financing Available Not Disclosed
Sale Yes
LegitScript Certified Yes
HIPAA Compliant Yes
Mobile App Not Disclosed
Supplies Included Cold-Packed
Free Shipping Yes
Expedited Shipping Yes
Discreet Packaging Yes
Format: Injection Brands: Zepbound Pen · Zepbound Vial
Offers Tirzepatide Yes
Offers Semaglutide Yes
Offers Brand Yes
Other Treatments Yes
Phone Not Disclosed
Address Not Disclosed
Provider Notes Compliance Compounded medications are not FDA-approved and are prescribed only when a clinician determines a compounded preparation produces a significant difference for the patient.
The FDA resolved the semaglutide shortage on April 22, 2025. Compounding is permitted only for individually identified patients when a prescribing practitioner determines that the compounded preparation produces a significant difference for their patient compared to the FDA-approved product.